Cholera Vaccines Market 2019 Forecast to 2024 by Market Standards, Industry Scope, Market Size with Revenue, Price, and Gross Margin

Press Release

Cholera Vaccines

This “Cholera Vaccines Market” report provides a detailed study on market and how it is impacting the industry. The report includes details of emerging trends, growth history, sales channel, manufacturers profiled in business, market share of product, application and regional scope of industry. In addition, the report also mentions opportunities that manufacturers operating in the global Cholera Vaccines market can use for expanding their business in untapped market to increase their customer base.

Request a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/14245307

Market Overview:

  • The growth of the global cholera vaccines market can be attributed to multiple factors, such as the increasing incidences of cholera, rising initiatives by public and private entities, and growing awareness regarding cholera across the world. In 2017, 10 million doses of oral cholera vaccines were funded in affected countries via stockpile. This stockpile has been accessed 52 times since the funding, by 18 countries across the world, including Sierra Leone and Haiti. However, a lack of access to adequate care for cholera, coupled with a large number of unreported cases, are expected to pull back the growth of the market.

    Cholera Vaccines Market Covers Manufacturers:

  • Astellas Pharma Inc.
  • AstraZeneca
  • Emergent BioSolutions Inc.
  • GlaxoSmithKline plc (GSK)
  • Merck & Co. Inc.
  • Mitsubishi Tanabe Pharma Corporation
  • PaxVax Inc.
  • Pfizer Inc.
  • Shantha Biotechnics Private Limited
  • Takeda Pharmaceutical Co. Ltd
  • Valneva SE

    Scope of the Report:

  • Cholera is caused by Vibrio cholerae via the consumption of contaminated food or water. The infected individuals suffer from severe watery diarrhea, eventually leading to dehydration, which if unattended, may lead to death, owing to access water loss. Oral vaccination has been observed to be the best preventive treatment for cholera and has proved to be very useful to prevent huge outbreaks. There are two basic types of vaccines given for cholera: whole-cell V. cholerae O1, in combination with a recombinant B-subunit of cholera toxin (WC/rBS), and killed oral O1 and O139.

    For More Information or Query or Customization Before Buying, Visit at @ https://www.industryresearch.co/enquiry/pre-order-enquiry/14245307

    Key Market Trends:

    Whole-cell V. cholerae O1 with a Recombinant B-subunit Segment Captures the Largest Market Share

    This oral cholera vaccine containing a combination of recombinant B-subunit and killed the whole cell V. cholerae O1 has been marketed since early 1990. This vaccine is observed to provide 80-90% protection for six months, post immunization, and in all the cases of immunization of vaccines aged more than 2 years. In addition to this, this vaccines shows around 50% of protection even after three years of immunization. Hence, the efficacy and long-lasting post immunization protections of the vaccine are expected to propel the segment’s growth over the forecast period.

    North America is Expected to Grow at a High Rate over the Forecast Period

    Asia-Pacific captures the largest market share in the global cholera vaccines market, followed by Europe. This can be attributed to the high incidence rate, growing awareness, and availability of efficient preventive solutions. The APAC market experienced exceptional growth since the launch of the oral cholera vaccine, Shanchol, in 2009. According to the statistics of WHO, 42 countries reported 172,454 cases of cholera in 2015, with 1,304 deaths. These statistics showed an overall decrease of 9% from the previous year, owing to growing immunization in the region. On the other hand, North America is expected to exhibit the fastest growth rate over the forecast period, owing to the launch of the first ever oral cholera vaccine, Vaxchora, in 2016, and the rise in the number of immigrants.

    Purchase this Report (Price 4250 USD for single user license) https://www.industryresearch.co/purchase/14245307

    Target Audience of Cholera Vaccines Market:

    • Manufacturer / Potential Investors
    • Traders, Distributors, Wholesalers, Retailers, Importers and Exporters.
    • Association and government bodies.

    Key Reasons to Cholera Vaccines Market Report:

    • Analyzing various perspectives of the Cholera Vaccines market with the help of Porter’s five forces analysis
    • The End User that is expected to dominate the Cholera Vaccines market is analyzed in detail
    • The regions which are expected to witness fastest growth during the forecast period are analyzed and estimated for growth of Cholera Vaccines market.
    • Identify the latest developments, market shares and strategies employed by the major market players.
    • Regional analysis of Cholera Vaccines market studied, during the forecast period
    • The segments that are expected to dominate the Cholera Vaccines market studied.

    For Detailed TOC Click Here

    About Industry Research:

    Industry Research is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in-depth market research. We are one of the top report resellers in the market, dedicated to bringing you an ingenious concoction of data parameters.

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]